Copertina

Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Spenser E. January, Keith A. Fester, Jesus E. Escamilla, Marlene Cano
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review
di: Hansa Mreyoud, et al.
Pubblicazione: (2024)

Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
di: Keith A. Rodvold
Pubblicazione: (2026)

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Yongyi Zhang, et al.
Pubblicazione: (2024)

Response to comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
di: Lily Price, et al.
Pubblicazione: (2024)

Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
di: Shawn Flanagan, et al.
Pubblicazione: (2024)

Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta‐analysis
di: Paweł Moćko, et al.
Pubblicazione: (2024)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
di: Lena Makortoff, et al.
Pubblicazione: (2024)

Assessment of Artificial Intelligence ( AI )‐Powered Self‐Care Recommendations for Management of Minor Ailments: A Comparative Analysis
di: Sham ZainAlAbdin, et al.
Pubblicazione: (2025)

Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders
di: Emily E. Leppien, et al.
Pubblicazione: (2024)

Assessment of the association between mixed‐oil lipid injectable emulsion use and 30‐day mortality or infection persistence from fungal catheter‐related bloodstream infections in pediatric patients following receipt of parenteral nutrition: A retrospective cohort study
di: Gustavo R. Alvira‐Arill, et al.
Pubblicazione: (2025)

Correction of posaconazole concentrations for hypoalbuminemia
di: David E. Nix, et al.
Pubblicazione: (2025)

Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After Admission for a Gastrointestinal Bleeding Event: Effectiveness and Safety of Direct Oral Anticoagulants Compared to Warfarin
di: Oluwadolapo D. Lawal, et al.
Pubblicazione: (2025)

Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
di: Iftekhar Ahmed, et al.
Pubblicazione: (2026)

Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case study
di: Cornelis F. Vos, et al.
Pubblicazione: (2024)

Adverse events with co‐prescription of angiotensin receptor blockers and clarithromycin compared to azithromycin: A population‐based retrospective cohort study
di: Nicholas C. Tonial, et al.
Pubblicazione: (2025)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
di: Mohammed Al Musawa, et al.
Pubblicazione: (2024)

Machine Learning‐Based Prediction of Prolonged Duration of Mechanical Ventilation Using Medication Data
di: Brian Murray, et al.
Pubblicazione: (2026)

Real‐World Cardiovascular Outcomes of GLP ‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
di: Cyrille K. Cornelio, et al.
Pubblicazione: (2026)

Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
di: Nicholas R. Nelson, et al.
Pubblicazione: (2024)

Corticosteroids in critically ill patients: A narrative review
di: Bradley J. Haan, et al.
Pubblicazione: (2024)

Impact of Dosing Interval Adherence on Pharmacokinetic Outcomes of Recombinant Erwinia Asparaginase in Pediatric Leukemia or Lymphoma
di: Milre M. Matherne, et al.
Pubblicazione: (2026)

Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis
di: Susan E. Smith, et al.
Pubblicazione: (2026)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
di: Mennatullah Hasan, et al.
Pubblicazione: (2024)

Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
di: Elizabeth M. Sherman, et al.
Pubblicazione: (2024)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
di: David B. Cluck, et al.
Pubblicazione: (2024)

Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
di: Rachel D. Harris, et al.
Pubblicazione: (2024)

Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial
di: Ian R. Woodcock, et al.
Pubblicazione: (2025)

Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries
di: Andrew D. Mosholder, et al.
Pubblicazione: (2024)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
di: Alexandre Duong, et al.
Pubblicazione: (2024)

Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
di: Maryam Aghakouchakzadeh, et al.
Pubblicazione: (2026)

Cancer Treatment Modalities and Female Fertility Preservation
di: Seonga Song, et al.
Pubblicazione: (2026)

Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
di: Atif Siddiqui
Pubblicazione: (2025)

Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
di: Jiwon Kim, et al.
Pubblicazione: (2025)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
di: Hua‐Ping Fan, et al.
Pubblicazione: (2024)

Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
di: Nicolette Centanni, et al.
Pubblicazione: (2025)

Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
di: Yi‐Fan Chien, et al.
Pubblicazione: (2025)

Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
di: Amanda Massmann, et al.
Pubblicazione: (2025)

In Search of Big Beautiful Biomarkers
di: C. Lindsay DeVane
Pubblicazione: (2025)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
di: Carlos Augusto Espinoza Cobeñas
Pubblicazione: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
di: Lisa T. Hong, et al.
Pubblicazione: (2024)